The increasing relevance of ‘technical character’
Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
- CMA costs case improves access to justice 30-06-2022
- Gilenya injunction bid: big pharma takeaways 21-06-2022
- Solving the PCT Priority problem 14-04-2022
- When alliances fail, is arbitration the answer? 24-02-2022
- Why mentorship matters 25-01-2022
Latest big pharma news
Japanese pharma company wins arbitration over cancer drug
16-08-2022
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.
